Crystalline composition containing escitalopram

Details for Australian Patent Application No. 2002355624 (hide)

Owner H. Lundbeck A/S

Inventors Andresen, Lene; Christensen, Troels Volsgaard; Assenza, Sebastian P.; Liljegren, Ken; Elema, Michiel Onne; Mahashbde, Shashank

Agent Watermark

Pub. Number AU-B-2002355624

PCT Number PCT/DK02/00513

PCT Pub. Number WO2003/011278

Priority PA 2001 01164 31.07.01 DK

Filing date 25 July 2002

Wipo publication date 17 February 2003

Acceptance publication date 2 February 2006

International Classifications

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): PA 2001 01164 31.07.01 DK

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002355624

2 February 2006 Application Accepted

  Published as AU-B-2002355624

1 June 2006 Standard Patent Sealed

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002355625-UNDERPANTS

2002355623-Novel 2,4-diaminothiazole derivatives